Author:
Park Jungsun,Shin Eunkyung,Hwang Gwang Rip,Kim Min-Kyeong,Joo Seongjae,Jeong Hyun Ju,Kim Jin Seok,Yoo Jaeil,Kim Junyoung
Abstract
Abstract
Background
The emergence of carbapenem-resistant Enterobacterales (CRE) infections is rapidly increasing and represents a serious public threat. In 2020, a total of 16,883 carbapenemase-producing Enterobacterales strains were collected; among these isolates, 21 strains were repeatedly isolated in a local tertiary care hospital.
Methods
Antimicrobial susceptibility testing was performed using the broth microdilution method. All 21 strains of CRKP were analyzed by PFGE after XbaI digestion. The 21 CRKP strains were sequenced on the Illumina Miseq and Oxford Nanopore GridION platforms.
Results
These 21 CRKP isolates showed an identical antimicrobial resistance profile, including resistance to ampicillin, carbapenems, cephems, chloramphenicol, fluoroquinolone, macrolides and trimethoprim/sulfamethoxazole. Based on whole-genome analysis, these 21 CRKP isolates shared a common genetic structure (ISAba125-IS630-blaNDM−1-bleMBL) and harbored additional resistance determinants (blaOXA−1, blaCTX−M−15, blaSHV−11, blaSHV−67, aac(6’)-Ib-cr, qnrS1, OqxA, OqxB, catB3, mph(A), sul1, and dfrA12) and mutations in the quinolone resistance-determining regions of gyrA (S83I) and parC (S80I). These isolates belonged to the ST147 and KL64 capsular types, which were carried on IncFIB replicon plasmids. The 21 CRKP strains collected from one hospital were divided into five PFGE patterns, and they were closely related with a minimum similarity value of 95.2%. These isolates were found to be highly related based on the presence of between 2 and 27 SNPs.
Conclusions
These findings indicate that NDM-1-producing K. pneumoniae ST147 may have been introduced via a common source, implying nosocomial transmission; furthermore, continuous monitoring is necessary to prevent endemic transmission.
Funder
Korea Disease Control and Prevention Agency
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference21 articles.
1. Yoon E-J, Yang JW, Kim JO, Lee H, Lee KJ, Jeong SH. Carbapenemase-producing Enterobacteriaceae in South Korea: a report from the National Laboratory Surveillance System. Future Microbiology. Future Medicine; 2018;13:771–83. Available from: https://doi.org/10.2217/fmb-2018-0022.
2. Seongjae Joo M, Kim E, Shin J, Kim J, Yoo. Molecular characteristic analysis and antimicrobial resistance of carbapenem-resistant Enterobacteriaceae(CRE) isolates in the Republic of Korea, 2017–2020. Public Health Weekly Report [Internet]. 2021; Available from: https://www.kdca.go.kr/board/board.es?mid=a30501000000&bid=0031&list_no=718138&act=view#.
3. Coelho A, Mirelis B, Alonso-Tarrés C, Larrosa MN, Miró E, Abad RC et al. Detection of three stable genetic clones of CTX-M-15-producing Klebsiella pneumoniae in the Barcelona metropolitan area, Spain. Journal of Antimicrobial Chemotherapy. 2009;64:862–4. Available from: https://doi.org/10.1093/jac/dkp264.
4. Damjanova I, Tóth Á, Pászti J, Hajbel-Vékony G, Jakab M, Berta J et al. Expansion and countrywide dissemination of ST11, ST15 and ST147 ciprofloxacin-resistant CTX-M-15-type β-lactamase-producing Klebsiella pneumoniae epidemic clones in Hungary in 2005—the new ‘MRSAs’? Journal of Antimicrobial Chemotherapy. 2008;62:978–85. Available from: https://doi.org/10.1093/jac/dkn287.
5. Peirano G, Chen L, Kreiswirth BN, Pitout JDD. Emerging Antimicrobial-Resistant High-Risk Klebsiella pneumoniae Clones ST307 and ST147. 2020. Available from: https://journals.asm.org/journal/aac.